These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8918246)

  • 1. A new series of mycobacterial expression vectors for the development of live recombinant vaccines.
    Baulard A; Kremer L; Supply P; Vidaud D; Bidart JM; Bellet D; Locht C
    Gene; 1996 Oct; 176(1-2):149-54. PubMed ID: 8918246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New use of BCG for recombinant vaccines.
    Stover CK; de la Cruz VF; Fuerst TR; Burlein JE; Benson LA; Bennett LT; Bansal GP; Young JF; Lee MH; Hatfull GF
    Nature; 1991 Jun; 351(6326):456-60. PubMed ID: 1904554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant BCG as a candidate oral vaccine vector.
    Barletta RG; Snapper B; Cirillo JD; Connell ND; Kim DD; Jacobs WR; Bloom BR
    Res Microbiol; 1990; 141(7-8):931-9. PubMed ID: 2101484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auxotrophic complementation as a selectable marker for stable expression of foreign antigens in Mycobacterium bovis BCG.
    Borsuk S; Mendum TA; Fagundes MQ; Michelon M; Cunha CW; McFadden J; Dellagostin OA
    Tuberculosis (Edinb); 2007 Nov; 87(6):474-80. PubMed ID: 17888740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant Mycobacterium bovis BCG.
    Bastos RG; Borsuk S; Seixas FK; Dellagostin OA
    Vaccine; 2009 Nov; 27(47):6495-503. PubMed ID: 19720367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression systems for study of mycobacterial gene regulation and development of recombinant BCG vaccines.
    DasGupta SK; Jain S; Kaushal D; Tyagi AK
    Biochem Biophys Res Commun; 1998 May; 246(3):797-804. PubMed ID: 9618292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant BCG approach for development of vaccines: cloning and expression of immunodominant antigens of M. tuberculosis.
    Dhar N; Rao V; Tyagi AK
    FEMS Microbiol Lett; 2000 Sep; 190(2):309-16. PubMed ID: 11034297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of heterologous HIV-1gp120 gene expression disruption in mycobacterium bovis BCG host strain: a critical issue for engineering mycobacterial based-vaccine vectors.
    Joseph J; Fernández-Lloris R; Pezzat E; Saubi N; Cardona PJ; Mothe B; Gatell JM
    J Biomed Biotechnol; 2010; 2010():357370. PubMed ID: 20617151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines.
    Aldovini A; Young RA
    Nature; 1991 Jun; 351(6326):479-82. PubMed ID: 2046750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant BCG as an antigen delivery system.
    Flynn JL
    Cell Mol Biol (Noisy-le-grand); 1994; 40 Suppl 1():31-6. PubMed ID: 7950859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant BCG vaccines: molecular features and their influence in the expression of foreign genes.
    Oliveira TL; Rizzi C; Dellagostin OA
    Appl Microbiol Biotechnol; 2017 Sep; 101(18):6865-6877. PubMed ID: 28779291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterologous expression of genes in mycobacteria.
    Triccas JA; Ryan AA
    Methods Mol Biol; 2009; 465():243-53. PubMed ID: 20560073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of BCG as a live recombinant vector system: potential use as an HIV vaccine.
    Fuerst TR; Stover CK; de la Cruz VF
    Biotechnol Ther; 1991; 2(1-2):159-78. PubMed ID: 1845119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable expression of Leptospira interrogans antigens in auxotrophic Mycobacterium bovis BCG.
    Seixas FK; Borsuk S; Fagundes MQ; Hartwig DD; Da Silva EF; Cerqueira GM; Dellagostin OA
    Biol Res; 2010; 43(1):13-8. PubMed ID: 21157628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning and sequencing of the merozoite surface antigen 2 gene from Plasmodium falciparum strain FCC-1/HN and expression of the gene in mycobacteria.
    Zheng C; Xie P; Chen Y
    J Eukaryot Microbiol; 2003; 50(2):140-3. PubMed ID: 12744528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Recombinant Mycobacterium bovis BCG Expression Vectors: Improving Genetic Control over Mycobacterial Promoters.
    Kanno AI; Goulart C; Rofatto HK; Oliveira SC; Leite LCC; McFadden J
    Appl Environ Microbiol; 2016 Apr; 82(8):2240-2246. PubMed ID: 26850295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel vaccination strategies based on recombinant Mycobacterium bovis BCG.
    Dietrich G; Viret JF; Hess J
    Int J Med Microbiol; 2003 Feb; 292(7-8):441-51. PubMed ID: 12635927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mercury resistance as a selective marker for recombinant mycobacteria.
    Baulard A; Escuyer V; Haddad N; Kremer L; Locht C; Berche P
    Microbiology (Reading); 1995 Apr; 141 ( Pt 4)():1045-50. PubMed ID: 7773382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The construction and expression of Rv3872 as a member of virulent protein secret system from Mycobacterium tuberculosis in Bacillus Calmette-Guerin].
    Shi XX; Bao L; Qiu YQ; Guo S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jun; 26(6):539-42. PubMed ID: 20487645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of heterologous genes in Mycobacterium bovis BCG: induction of a cellular response against HIV-1 Nef protein.
    Winter N; Lagranderie M; Rauzier J; Timm J; Leclerc C; Guy B; Kieny MP; Gheorghiu M; Gicquel B
    Gene; 1991 Dec; 109(1):47-54. PubMed ID: 1756981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.